While the US health regulator did not specify details for issuing the alert, it said 'detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices'.
Alleging that the candidate vaccine was not safe, he has also sought cancelling approval for its testing, 'manufacture and distribution', failing which legal action would be taken.
Maharashtra Chief Minister Uddhav Thackeray on Sunday night announced a statewide curfew in Maharashtra for 15 days from April 14. However, he clarified, essential services were exempt from the curbs.
RPG Life already has marketing tie-ups with Israel's drug major Teva for the EU market and with the US-based Apotex for the Canadian market.
The US Food and Drug Administration has asked USV to probe employees who might have been responsible for inaccurate data reporting.
The three Indian companies are Alpha Design Technologies Pvt Ltd, Bharat Forge Ltd and Medha Servo Drives Pvt Ltd, the space organisation said in a statement on Friday.
Last year, the USFDA had banned 30 generic drugs produced at Ranbaxy's plants at Poanta Sahib.
A report by the Azim Premji University showed that during the pandemic 270 million Indians were pushed into poverty. Meaning that they were not poor according to the government poverty line before, but have become now. Aakar Patel mulls on the state of the nation as the Modi government enters its eighth year.
It is the most potent symbol of India's soft power -- more perhaps than the IT industry and our managerial skill, notes Vanita Kohli-Khandekar
The Indian Council of Medical Research will start national-level sero surveys to assess the spread of Covid-19 and all states/Union territories should also be encouraged to conduct them so that information from all geographies can be collected, the Union health ministry said on Friday.
Check out some of the stocks that will react on the basis of their numbers in the near term.
Sun Pharmaceutical Industries said it has received approval from US health regulator to market generic Clarinex tablets and Tiazac capsules, used in treating nasal allergies and hypertension, respectively, in the American market.
The company said this was 'important' to reinforce the 'complete disassociation' from its erstwhile promoters -- Malvinder and Shivinder Singh.
The Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 per cent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.
According to Sebi's listing obligations and disclosure requirements, a company has to report any fraud, default by promoter or arrest of key managerial persons or promoters as it is a material event.
The company had posted a consolidated net profit of Rs 323.31 crore (Rs 3.23 billion) in the same period last fiscal, Wockhardt Ltd said in a filing to the Bombay Stock Exchange.
Leading pharmaceutical firms such as Cipla and Ranbaxy are among the firms pulled up by the drug price regulator National Pharmaceuticals Pricing Authority (NPPA) for overcharging.
In May this year, Ranbaxy had pleaded guilty to 'felony charges' for violating manufacturing norms and agreed to pay $500 million penalty to US authorities.
A 26-year-old Indian employee at an IT firm, who was accused of murdering an American woman, was found dead after he allegedly committed suicide due to suspected drug overdose at a New Jersey hotel.
The increased vigil comes after the Narcotics Control Bureau recently busted two international syndicates operating through a call centre and a software firm to smuggle Psychotropic drugs overseas. NCB seized over 90,000 regulated and banned tablets valued at over Rs one crore in the international market that were to be smuggled out.
In India, thousands of lives are lost every year because of unavailability of organs
This is the fifth consecutive day that COVID-19 cases have increased by more than 50,000 in the country.
'What really works is the core story, the characters who come together, the twists and turns, and, above all, Sushmita Sen,' notes Joginder Tuteja.
The bouquet of Covid-19 tests that most diagnostic labs are offering include antibody tests (blood tests), rapid antigen tests (point of care tests that detect the presence of an antigen from a nasal or throat swab in case of SARS-CoV-2), and reverse transcription-polymerase chain reaction (RT-PCR) tests.
The Indian Medical Association and the Mumbai Association of Medical Consultant have written a letter to Narendra Modi expressing disappointment over his statement during the Bharat ki Baat Sabke saath event in London.
This acquisition marks Lupin's foray into the Japanese branded market in-line with aspirations to build business globally.
Global pharma firm AstraZeneca on Tuesday said it had filed a lawsuit in the United States District Court of New Jersey
Mitra Biotech's personalised cancer therapy could be a game changer in the field of cancer medicine.
The R&D plan, focused on diseases affecting poor nations, is expected to be ready by 2008 and may benefit Indian drug firms and contract research organisations in a big way.
The economics and pricing of the Covishield vaccines and the government's own decision to pay higher prices raise more than a few questions, observes Prosenjit Datta.
Before being appointed as the Mumbai police chief, Singh was posted as the Director General of the Maharashtra Anti Corruption Bureau.
Sun Pharma's acquisition of Ranbaxy has once again revived evaluation of the troubled past of the latter, which had changed hands from the promoters merely five years ago.
The GoM was apprised that as of now, the death rate is around 3.1 per cent while the recovery rate is more than 20 per cent, which is comparatively better than most of the countries and may be taken as a positive effect of the lockdown in the country, along with the cluster management and containment strategy.
The Supreme Court on Monday posed some tough questions to a lawyer, asking him to substantiate his "unfounded allegations" in a PIL that Indian pharma major Ranbaxy Laboratories Ltd was allegedly manufacturing and selling adulterated medicines.
Is yet to decide about the partnership or acquisition route
The multinational has filed infringement proceedings and is seeking an injunction against the Indian rival at the Delhi High Court, trying to block the Bangalore-based biotechnology firm from launching a generic version of Galvus, also known as vildagliptin.
The patent relates to the manufacturing process for the active ingredient in Sanofi-Aventis' Allegra and Allegra-D drug products. Both Dr Reddys and Sandoz are known to be marketing these products in the US.
Pharma industry lauds idea, but suggests looser rules on ground
Pfizer had approached the court accusing Mumbai-based Ultratech India Ltd of adopting the name 'Fiagra', which was deceptively similar to its drug 'Vigara', to pass of its drug as that of the American company.\n\n\n\n
Experts say despite it being a global deal, the transaction will have to undergo CCI scrutiny because of the scale of operations.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances